Is InspireMD Inc (NSPR) overvalued? · rev $7.0M
InspireMD Inc (NSPR) is a medical devices company listed on NASDAQ.
This page asks whether InspireMD Inc (NSPR) looks expensive on cached numbers — not a short thesis.
Latest reported NSPR revenue for 2024-12-31 was $7.0M. Net income was -$32.0M. Revenue was up 13.0% from 2023-12-31 to 2024-12-31. NSPR currently screens at market cap $34.6M.
NSPR currently screens at market cap $34.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NSPR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NSPR stock page for the full model, not this heading.
Not investment advice.